Philips has rolled out an AI-driven tool, DeviceGuide, intended to support clinicians during intricate cardiac interventions, particularly the minimally invasive repair of leaking valves of the heart, known medically as mitral valve regurgitation.
The device tracking tool is built on the company’s EchoNavigator system. It is designed to translate complex imaging data into real-time visuals, assisting healthcare professionals as they manoeuvre within the moving heart.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Mitral valve regurgitation occurs when blood leaks backwards through the valve. The company noted that, for individuals considered unsuitable for open-heart surgery, minimally invasive methods like mitral transcatheter edge-to-edge repair (M-TEER) are available.
This approach involves accessing the heart via a small cut in the groin and directing instruments through the blood vessels to position a repair device.
These procedures demand that clinicians interpret X-ray and ultrasound images across several monitors, synchronise actions between two operators, and make adjustments to the repair apparatus, all while the heart continues beating.
DeviceGuide supports this process by offering 3D navigation guidance.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataLeveraging AI algorithms, the solution automatically follows the path of the small repair device inside the heart.
It merges live X-ray and echo images to generate a real-time 3D representation of the device, which is projected onto live imaging feeds of the heart.
This enables medical teams to visualise the device’s position and orientation, potentially making it easier to close valve leaks.
The solution was developed through a partnership with Edwards Lifesciences. The partnership focused on improving key workflow steps during mitral TEER procedures.
Philips diagnosis and treatment chief medical officer Dr Atul Gupta said: “With DeviceGuide, we’re bringing AI into the heart of the procedure room, and into the heart itself.
“This is Philips’ first AI assisting physicians in real time to visualise and guide heart valve treatment devices as they navigate the beating heart. It’s helping doctors in the moment as they are helping their patients with structural heart disease.”
In September 2025, Philips and Masimo extended their strategic partnership to develop solutions for patient care.
